# Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases

> **NCT02080949** · PHASE1 · WITHDRAWN · sponsor: **Barretos Cancer Hospital**

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** 4fx x 5Gy

## Key facts

- **NCT ID:** NCT02080949
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Low rate of recruitment.
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080949, "Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02080949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*